Trial · NCT02470403
Participant flow25
How many started, completed or left each group, period by period.
1 to 20 of 25
Download this page as JSON| Period | Milestone | Group | Participants | Units counted |
|---|---|---|---|---|
| Overall Study | STARTED | Part 1: LIK066 150 mg Once Daily (qd) | 44 | |
| Overall Study | STARTED | Part 1: Placebo Once Daily | 44 | |
| Overall Study | STARTED | Part 2: LIK066 75 mg Twice Daily (Bid) | 40 | |
| Overall Study | STARTED | Part 2: LIK066 50 mg Three Times Daily (Tid) | 43 | |
| Overall Study | STARTED | Part 2: Placebo Three Times Daily | 10 | |
| Overall Study | Dysglycemic | Part 1: LIK066 150 mg Once Daily (qd) | 24 | |
| Overall Study | Dysglycemic | Part 1: Placebo Once Daily | 24 | |
| Overall Study | Dysglycemic | Part 2: LIK066 75 mg Twice Daily (Bid) | 20 | |
| Overall Study | Dysglycemic | Part 2: LIK066 50 mg Three Times Daily (Tid) | 20 | |
| Overall Study | Dysglycemic | Part 2: Placebo Three Times Daily | 5 | |
| Overall Study | Normoglycemic | Part 1: LIK066 150 mg Once Daily (qd) | 20 | |
| Overall Study | Normoglycemic | Part 1: Placebo Once Daily | 20 | |
| Overall Study | Normoglycemic | Part 2: LIK066 75 mg Twice Daily (Bid) | 20 | |
| Overall Study | Normoglycemic | Part 2: LIK066 50 mg Three Times Daily (Tid) | 23 | |
| Overall Study | Normoglycemic | Part 2: Placebo Three Times Daily | 5 | |
| Overall Study | COMPLETED | Part 1: LIK066 150 mg Once Daily (qd) | 42 | |
| Overall Study | COMPLETED | Part 1: Placebo Once Daily | 43 | |
| Overall Study | COMPLETED | Part 2: LIK066 75 mg Twice Daily (Bid) | 40 | |
| Overall Study | COMPLETED | Part 2: LIK066 50 mg Three Times Daily (Tid) | 39 | |
| Overall Study | COMPLETED | Part 2: Placebo Three Times Daily | 10 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT02470403/flow